Copyright Reports & Markets. All rights reserved.

Global Companion Diagnostic Tests in Oncology Market Size, Status and Forecast 2020-2026

Request for Sample of this report
Buy now

1 Report Overview

  • 1.1 Study Scope
  • 1.2 Key Market Segments
  • 1.3 Market Analysis by Type
    • 1.3.1 Global Companion Diagnostic Tests in Oncology Market Size Growth Rate by Type: 2020 VS 2026
    • 1.3.2 Protein Detection
    • 1.3.3 DNA Detection
  • 1.4 Market by Application
    • 1.4.1 Global Companion Diagnostic Tests in Oncology Market Share by Application: 2020 VS 2026
    • 1.4.2 Pharmaceutical & Biotechnology Companies
    • 1.4.3 Medical Device Companies
    • 1.4.4 Research Institutes
    • 1.4.5 Others
  • 1.5 Study Objectives
  • 1.6 Years Considered

2 Global Growth Trends

  • 2.1 Global Companion Diagnostic Tests in Oncology Market Perspective (2015-2026)
  • 2.2 Companion Diagnostic Tests in Oncology Growth Trends by Regions
    • 2.2.1 Companion Diagnostic Tests in Oncology Market Size by Regions: 2015 VS 2020 VS 2026
    • 2.2.2 Companion Diagnostic Tests in Oncology Historic Market Share by Regions (2015-2020)
    • 2.2.3 Companion Diagnostic Tests in Oncology Forecasted Market Size by Regions (2021-2026)
  • 2.3 Companion Diagnostic Tests in Oncology Industry Dynamic
    • 2.3.1 Companion Diagnostic Tests in Oncology Market Trends
    • 2.3.2 Companion Diagnostic Tests in Oncology Market Drivers
    • 2.3.3 Companion Diagnostic Tests in Oncology Market Challenges
    • 2.3.4 Companion Diagnostic Tests in Oncology Market Restraints

3 Competition Landscape by Key Players

  • 3.1 Global Top Companion Diagnostic Tests in Oncology Players by Market Size
    • 3.1.1 Global Top Companion Diagnostic Tests in Oncology Players by Revenue (2015-2020)
    • 3.1.2 Global Companion Diagnostic Tests in Oncology Revenue Market Share by Players (2015-2020)
  • 3.2 Global Companion Diagnostic Tests in Oncology Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
  • 3.3 Players Covered: Ranking by Companion Diagnostic Tests in Oncology Revenue
  • 3.4 Global Companion Diagnostic Tests in Oncology Market Concentration Ratio
    • 3.4.1 Global Companion Diagnostic Tests in Oncology Market Concentration Ratio (CR5 and HHI)
    • 3.4.2 Global Top 10 and Top 5 Companies by Companion Diagnostic Tests in Oncology Revenue in 2019
  • 3.5 Key Players Companion Diagnostic Tests in Oncology Area Served
  • 3.6 Key Players Companion Diagnostic Tests in Oncology Product Solution and Service
  • 3.7 Date of Enter into Companion Diagnostic Tests in Oncology Market
  • 3.8 Mergers & Acquisitions, Expansion Plans

4 Companion Diagnostic Tests in Oncology Breakdown Data by Type

  • 4.1 Global Companion Diagnostic Tests in Oncology Historic Market Size by Type (2015-2020)
  • 4.2 Global Companion Diagnostic Tests in Oncology Forecasted Market Size by Type (2021-2026)

5 Companion Diagnostic Tests in Oncology Breakdown Data by Application

  • 5.1 Global Companion Diagnostic Tests in Oncology Historic Market Size by Application (2015-2020)
  • 5.2 Global Companion Diagnostic Tests in Oncology Forecasted Market Size by Application (2021-2026)

6 North America

  • 6.1 North America Companion Diagnostic Tests in Oncology Market Size (2015-2026)
  • 6.2 North America Companion Diagnostic Tests in Oncology Market Size by Type (2015-2020)
  • 6.3 North America Companion Diagnostic Tests in Oncology Market Size by Application (2015-2020)
  • 6.4 North America Companion Diagnostic Tests in Oncology Market Size by Country (2015-2020)
    • 6.4.1 United States
    • 6.4.2 Canada

7 Europe

  • 7.1 Europe Companion Diagnostic Tests in Oncology Market Size (2015-2026)
  • 7.2 Europe Companion Diagnostic Tests in Oncology Market Size by Type (2015-2020)
  • 7.3 Europe Companion Diagnostic Tests in Oncology Market Size by Application (2015-2020)
  • 7.4 Europe Companion Diagnostic Tests in Oncology Market Size by Country (2015-2020)
    • 7.4.1 Germany
    • 7.4.2 France
    • 7.4.3 U.K.
    • 7.4.4 Italy
    • 7.4.5 Russia
    • 7.4.6 Nordic

8 Asia-Pacific

  • 8.1 Asia-Pacific Companion Diagnostic Tests in Oncology Market Size (2015-2026)
  • 8.2 Asia-Pacific Companion Diagnostic Tests in Oncology Market Size by Type (2015-2020)
  • 8.3 Asia-Pacific Companion Diagnostic Tests in Oncology Market Size by Application (2015-2020)
  • 8.4 Asia-Pacific Companion Diagnostic Tests in Oncology Market Size by Region (2015-2020)
    • 8.4.1 China
    • 8.4.2 Japan
    • 8.4.3 South Korea
    • 8.4.4 Southeast Asia
    • 8.4.5 India
    • 8.4.6 Australia

9 Latin America

  • 9.1 Latin America Companion Diagnostic Tests in Oncology Market Size (2015-2026)
  • 9.2 Latin America Companion Diagnostic Tests in Oncology Market Size by Type (2015-2020)
  • 9.3 Latin America Companion Diagnostic Tests in Oncology Market Size by Application (2015-2020)
  • 9.4 Latin America Companion Diagnostic Tests in Oncology Market Size by Country (2015-2020)
    • 9.4.1 Mexico
    • 9.4.2 Brazil

10 Middle East & Africa

  • 10.1 Middle East & Africa Companion Diagnostic Tests in Oncology Market Size (2015-2026)
  • 10.2 Middle East & Africa Companion Diagnostic Tests in Oncology Market Size by Type (2015-2020)
  • 10.3 Middle East & Africa Companion Diagnostic Tests in Oncology Market Size by Application (2015-2020)
  • 10.4 Middle East & Africa Companion Diagnostic Tests in Oncology Market Size by Country (2015-2020)
    • 10.4.1 Turkey
    • 10.4.2 Saudi Arabia
    • 10.4.3 UAE

11Key Players Profiles

  • 11.1 Abbott
    • 11.1.1 Abbott Company Details
    • 11.1.2 Abbott Business Overview
    • 11.1.3 Abbott Companion Diagnostic Tests in Oncology Introduction
    • 11.1.4 Abbott Revenue in Companion Diagnostic Tests in Oncology Business (2015-2020))
    • 11.1.5 Abbott Recent Development
  • 11.2 Roche
    • 11.2.1 Roche Company Details
    • 11.2.2 Roche Business Overview
    • 11.2.3 Roche Companion Diagnostic Tests in Oncology Introduction
    • 11.2.4 Roche Revenue in Companion Diagnostic Tests in Oncology Business (2015-2020)
    • 11.2.5 Roche Recent Development
  • 11.3 Genomic Health
    • 11.3.1 Genomic Health Company Details
    • 11.3.2 Genomic Health Business Overview
    • 11.3.3 Genomic Health Companion Diagnostic Tests in Oncology Introduction
    • 11.3.4 Genomic Health Revenue in Companion Diagnostic Tests in Oncology Business (2015-2020)
    • 11.3.5 Genomic Health Recent Development
  • 11.4 QIAGEN
    • 11.4.1 QIAGEN Company Details
    • 11.4.2 QIAGEN Business Overview
    • 11.4.3 QIAGEN Companion Diagnostic Tests in Oncology Introduction
    • 11.4.4 QIAGEN Revenue in Companion Diagnostic Tests in Oncology Business (2015-2020)
    • 11.4.5 QIAGEN Recent Development
  • 11.5 Agilent
    • 11.5.1 Agilent Company Details
    • 11.5.2 Agilent Business Overview
    • 11.5.3 Agilent Companion Diagnostic Tests in Oncology Introduction
    • 11.5.4 Agilent Revenue in Companion Diagnostic Tests in Oncology Business (2015-2020)
    • 11.5.5 Agilent Recent Development
  • 11.6 Agendia
    • 11.6.1 Agendia Company Details
    • 11.6.2 Agendia Business Overview
    • 11.6.3 Agendia Companion Diagnostic Tests in Oncology Introduction
    • 11.6.4 Agendia Revenue in Companion Diagnostic Tests in Oncology Business (2015-2020)
    • 11.6.5 Agendia Recent Development
  • 11.7 BioMerieux
    • 11.7.1 BioMerieux Company Details
    • 11.7.2 BioMerieux Business Overview
    • 11.7.3 BioMerieux Companion Diagnostic Tests in Oncology Introduction
    • 11.7.4 BioMerieux Revenue in Companion Diagnostic Tests in Oncology Business (2015-2020)
    • 11.7.5 BioMerieux Recent Development
  • 11.8 Illumina
    • 11.8.1 Illumina Company Details
    • 11.8.2 Illumina Business Overview
    • 11.8.3 Illumina Companion Diagnostic Tests in Oncology Introduction
    • 11.8.4 Illumina Revenue in Companion Diagnostic Tests in Oncology Business (2015-2020)
    • 11.8.5 Illumina Recent Development
  • 11.9 Siemens Healthcare
    • 11.9.1 Siemens Healthcare Company Details
    • 11.9.2 Siemens Healthcare Business Overview
    • 11.9.3 Siemens Healthcare Companion Diagnostic Tests in Oncology Introduction
    • 11.9.4 Siemens Healthcare Revenue in Companion Diagnostic Tests in Oncology Business (2015-2020)
    • 11.9.5 Siemens Healthcare Recent Development
  • 11.10 Thermo Fisher
    • 11.10.1 Thermo Fisher Company Details
    • 11.10.2 Thermo Fisher Business Overview
    • 11.10.3 Thermo Fisher Companion Diagnostic Tests in Oncology Introduction
    • 11.10.4 Thermo Fisher Revenue in Companion Diagnostic Tests in Oncology Business (2015-2020)
    • 11.10.5 Thermo Fisher Recent Development

12Analyst's Viewpoints/Conclusions

    13Appendix

    • 13.1 Research Methodology
      • 13.1.1 Methodology/Research Approach
      • 13.1.2 Data Source
    • 13.2 Disclaimer

    Companion Diagnostic Tests in Oncology market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Companion Diagnostic Tests in Oncology market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2015-2026.

    Market segment by Type, the product can be split into
    Protein Detection
    DNA Detection

    Market segment by Application, split into
    Pharmaceutical & Biotechnology Companies
    Medical Device Companies
    Research Institutes
    Others

    Based on regional and country-level analysis, the Companion Diagnostic Tests in Oncology market has been segmented as follows:
    North America
    United States
    Canada
    Europe
    Germany
    France
    U.K.
    Italy
    Russia
    Nordic
    Asia-Pacific
    China
    Japan
    South Korea
    Southeast Asia
    India
    Australia
    Latin America
    Mexico
    Brazil
    Middle East & Africa
    Turkey
    Saudi Arabia
    UAE

    In the competitive analysis section of the report, leading as well as prominent players of the global Companion Diagnostic Tests in Oncology market are broadly studied on the basis of key factors. The report offers comprehensive analysis and accurate statistics on revenue by the player for the period 2015-2020. It also offers detailed analysis supported by reliable statistics on price and revenue (global level) by player for the period 2015-2020.
    The key players covered in this study
    Abbott
    Roche
    Genomic Health
    QIAGEN
    Agilent
    Agendia
    BioMerieux
    Illumina
    Siemens Healthcare

    Buy now